Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-15

FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic Naproxen product from Hikma Pharmaceuticals USA Inc. This action expands access to Naproxen under an a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN)